131 related articles for article (PubMed ID: 7578074)
1. Heme stoichiometry of heterodimeric soluble guanylate cyclase.
Stone JR; Marletta MA
Biochemistry; 1995 Nov; 34(45):14668-74. PubMed ID: 7578074
[TBL] [Abstract][Full Text] [Related]
2. Spectral and kinetic studies on the activation of soluble guanylate cyclase by nitric oxide.
Stone JR; Marletta MA
Biochemistry; 1996 Jan; 35(4):1093-9. PubMed ID: 8573563
[TBL] [Abstract][Full Text] [Related]
3. Soluble guanylate cyclase from bovine lung: activation with nitric oxide and carbon monoxide and spectral characterization of the ferrous and ferric states.
Stone JR; Marletta MA
Biochemistry; 1994 May; 33(18):5636-40. PubMed ID: 7910035
[TBL] [Abstract][Full Text] [Related]
4. Localization of the heme binding region in soluble guanylate cyclase.
Zhao Y; Marletta MA
Biochemistry; 1997 Dec; 36(50):15959-64. PubMed ID: 9398330
[TBL] [Abstract][Full Text] [Related]
5. The ferrous heme of soluble guanylate cyclase: formation of hexacoordinate complexes with carbon monoxide and nitrosomethane.
Stone JR; Marletta MA
Biochemistry; 1995 Dec; 34(50):16397-403. PubMed ID: 8845366
[TBL] [Abstract][Full Text] [Related]
6. A functional heme-binding site of soluble guanylyl cyclase requires intact N-termini of alpha 1 and beta 1 subunits.
Foerster J; Harteneck C; Malkewitz J; Schultz G; Koesling D
Eur J Biochem; 1996 Sep; 240(2):380-6. PubMed ID: 8841402
[TBL] [Abstract][Full Text] [Related]
7. Purification of bovine soluble guanylate cyclase and ADP-ribosylation on its small subunit by bacterial toxins.
Tomita T; Tsuyama S; Imai Y; Kitagawa T
J Biochem; 1997 Sep; 122(3):531-6. PubMed ID: 9348080
[TBL] [Abstract][Full Text] [Related]
8. Control of nitric oxide dynamics by guanylate cyclase in its activated state.
Négrerie M; Bouzhir L; Martin JL; Liebl U
J Biol Chem; 2001 Dec; 276(50):46815-21. PubMed ID: 11590135
[TBL] [Abstract][Full Text] [Related]
9. Identification of residues crucially involved in the binding of the heme moiety of soluble guanylate cyclase.
Schmidt PM; Schramm M; Schröder H; Wunder F; Stasch JP
J Biol Chem; 2004 Jan; 279(4):3025-32. PubMed ID: 14570894
[TBL] [Abstract][Full Text] [Related]
10. Characterization of functional heme domains from soluble guanylate cyclase.
Karow DS; Pan D; Davis JH; Behrends S; Mathies RA; Marletta MA
Biochemistry; 2005 Dec; 44(49):16266-74. PubMed ID: 16331987
[TBL] [Abstract][Full Text] [Related]
11. Activation of purified soluble guanylate cyclase by arachidonic acid requires absence of enzyme-bound heme.
Ignarro LJ; Wood KS
Biochim Biophys Acta; 1987 Apr; 928(2):160-70. PubMed ID: 2882783
[TBL] [Abstract][Full Text] [Related]
12. Activation of purified guanylate cyclase by nitric oxide requires heme. Comparison of heme-deficient, heme-reconstituted and heme-containing forms of soluble enzyme from bovine lung.
Ignarro LJ; Degnan JN; Baricos WH; Kadowitz PJ; Wolin MS
Biochim Biophys Acta; 1982 Sep; 718(1):49-59. PubMed ID: 6128034
[TBL] [Abstract][Full Text] [Related]
13. Dynamic change of heme environment in soluble guanylate cyclase and complexation of NO-independent drug agents with H-NOX domain.
Alisaraie L; Fu Y; Tuszynski JA
Chem Biol Drug Des; 2013 Mar; 81(3):359-81. PubMed ID: 23095288
[TBL] [Abstract][Full Text] [Related]
14. Activation of soluble guanylate cyclase by NO-hemoproteins involves NO-heme exchange. Comparison of heme-containing and heme-deficient enzyme forms.
Ignarro LJ; Adams JB; Horwitz PM; Wood KS
J Biol Chem; 1986 Apr; 261(11):4997-5002. PubMed ID: 2870064
[TBL] [Abstract][Full Text] [Related]
15. Guanylate cyclase from bovine lung. Evidence that enzyme activation by phenylhydrazine is mediated by iron-phenyl hemoprotein complexes.
Ignarro LJ; Wood KS; Ballot B; Wolin MS
J Biol Chem; 1984 May; 259(9):5923-31. PubMed ID: 6143758
[TBL] [Abstract][Full Text] [Related]
16. Quaternary structure controls ligand dynamics in soluble guanylate cyclase.
Yoo BK; Lamarre I; Martin JL; Negrerie M
J Biol Chem; 2012 Feb; 287(9):6851-9. PubMed ID: 22223482
[TBL] [Abstract][Full Text] [Related]
17. NO and CO differentially activate soluble guanylyl cyclase via a heme pivot-bend mechanism.
Ma X; Sayed N; Beuve A; van den Akker F
EMBO J; 2007 Jan; 26(2):578-88. PubMed ID: 17215864
[TBL] [Abstract][Full Text] [Related]
18. Characterization of 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one as a heme-site inhibitor of nitric oxide-sensitive guanylyl cyclase.
Schrammel A; Behrends S; Schmidt K; Koesling D; Mayer B
Mol Pharmacol; 1996 Jul; 50(1):1-5. PubMed ID: 8700100
[TBL] [Abstract][Full Text] [Related]
19. A constitutively activated mutant of human soluble guanylyl cyclase (sGC): implication for the mechanism of sGC activation.
Martin E; Sharina I; Kots A; Murad F
Proc Natl Acad Sci U S A; 2003 Aug; 100(16):9208-13. PubMed ID: 12883009
[TBL] [Abstract][Full Text] [Related]
20. Efficient expression of human soluble guanylate cyclase in Escherichia coli and its signaling-related interaction with nitric oxide.
Zhong F; Wang H; Ying T; Huang ZX; Tan X
Amino Acids; 2010 Jul; 39(2):399-408. PubMed ID: 20063108
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
